Project deliverable Open Access

SIMCor. Deliverable 7.2: Definition of model templates (TUE, M9)

Huberts, Wouter

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="" xmlns="" xsi:schemaLocation="">
  <identifier identifierType="DOI">10.5281/zenodo.6146529</identifier>
      <creatorName>Huberts, Wouter</creatorName>
      <affiliation>Technische Universiteit Eindhoven</affiliation>
    <title>SIMCor. Deliverable 7.2: Definition of model templates (TUE, M9)</title>
    <date dateType="Issued">2021-09-30</date>
  <resourceType resourceTypeGeneral="Text">Project deliverable</resourceType>
    <alternateIdentifier alternateIdentifierType="url"></alternateIdentifier>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.6146528</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf"></relatedIdentifier>
    <rights rightsURI="">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
    <description descriptionType="Abstract">&lt;p&gt;The deliverable describes the preliminary definition of model templates that will be used during virtual cohort generation of both aortic valve disease and heart failure patients. The document gives an overview of the available models for simulating the physiology of these patient groups, both before and after transcatheter aortic valve implantation or insertion of a pulmonary artery pressure sensor, respectively. In addition, it describes the intended use of these models. Thereafter, it is presented how the optimal model complexity of our virtual cohort generator is selected, and how the models are validated on patient-level. Moreover, the document discusses surrogate models that are currently selected as potential candidates for fast model evaluations during uncertainty quantification, sensitivity analyses and virtual cohort generation. Finally, we describe how we envision integration of the model templates into the virtual research environment, and we speculate on future strategies for mapping engineering metrics into clinical outcomes.&lt;/p&gt;</description>
    <description descriptionType="Other">SIMCor (In-Silico testing and validation of Cardiovascular IMplantable devices) has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101017578.</description>
      <funderName>European Commission</funderName>
      <funderIdentifier funderIdentifierType="Crossref Funder ID">10.13039/100010661</funderIdentifier>
      <awardNumber awardURI="info:eu-repo/grantAgreement/EC/Horizon 2020 Framework Programme - Research and Innovation action/101017578/">101017578</awardNumber>
      <awardTitle>In Silico testing and validation of Cardiovascular Implantable devices</awardTitle>
All versions This version
Views 2121
Downloads 2424
Data volume 19.0 MB19.0 MB
Unique views 1616
Unique downloads 2121


Cite as